Constellation Pharmaceuticals, Inc. announced that Jeffrey Humphrey, M.D., will join the company as Chief Medical Officer. Adrian Senderowicz, M.D., the company’s current Chief Medical Officer, will transition to the role of Senior Advisor, where he will continue to advise Constellation on initiatives in research and development, translational science and corporate strategy. The appointment of Dr. Humphrey as Chief Medical Officer and transition of Dr. Senderowicz to a Senior Advisor of Constellation will be effective as of June 22, 2020.